Transcription of MEDICAL POLICY – 2.01
{{id}} {{{paragraph}}}
Example: dental hygienist
MEDICAL POLICY – 2.01
MEDICAL POLICY Orthopedic Applications of Platelet-Rich Plasma BCBSA Ref. POLICY : Effective Date: July 1, 2021 RELATED MEDICAL POLICIES: Last Revised: June 1, 2021 Recombinant and Autologous Platelet-Derived Growth Factors for Replaces: N/A Wound Healing and Other Non Orthopedic Conditions Prolotherapy Orthopedic Applications of Stem Cell Therapy (Including Allografts and Bone Substitutes Used with Autologous Bone Marrow). Select a hyperlink below to be directed to that section. POLICY CRITERIA | CODING | RELATED INFORMATION.
Autologous fibrin sealants can be created from platelet - poor plasma. This policy does not address the use of fibrin sealants. ... technology results in an improvement in the net health outcomes. Primary Treatment for Non‒Tendon Soft Tissue Injury or Inflammation ... and high risk of bias in study conduct.
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: